Evidence map›Paper›PMID 12711636›Full record

ArticleBritish journal of pharmacology2003

Opposite nociceptive effects of the arginine/NO/cGMP pathway stimulation in dermal and subcutaneous tissues.

Gustavo G Vivancos, Carlos A Parada, Sérgio H Ferreira

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. International journal of molecular sciences · 2025
    Article
  3. Article
  4. Methanol Extract ofBiomolecules · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Skin vasodilation and analgesic effect of a topical nitric oxide-releasing hydrogel.Journal of materials science. Materials in medicine · 2013
    Article
  9. Peripheral inflammatory hyperalgesia depends on the COX increase in the dorsal root ganglion.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  10. Article
  11. Article
  12. Morphine peripheral analgesia depends on activation of the PI3Kgamma/AKT/nNOS/NO/KATP signaling pathway.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  13. Article
  14. Nitric oxide as an endogenous peripheral modulator of visceral sensory neuronal function.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2009
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gustavo G VivancosDepartment of Pharmacology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, 14049-900, Monte Alegre, Ribeirão Preto, São Paulo, Brazil.
Carlos A Parada
Sérgio H Ferreira
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

1. Nitric oxide has been described either as pronociceptive or antinociceptive. In this investigation, using an electronic pressure-metre, the intradermal and the subcutaneous effects of prostaglandin E(2) (PGE(2)) and agents that mimic or inhibit the arginine/NO/cGMP pathway were compared. 2. The hypernociceptive effect of the intradermal injection of PGE(2) (100 ng) was immediate, peaking within 15-30 min and returning to basal values in 45-60 min. The subcutaneous injection of PGE(2) induced a hypernociception with a delayed peak (3 h) plateauing for 4-6 h. 3. Intradermal administration of 3-morpholino-sydnonimine-hydrochloride (SIN-1) enhanced, while its subcutaneous administration inhibited, subcutaneous hypernociception induced by PGE(2). This inhibition was prevented by ODQ (8 micro g) but not by NG-monomethyl-L-arginine (L-NMMA) (50 micro g). 4. Intradermal but not subcutaneous administration of L-arginine (1-100 micro g), SIN-1 (1-100 micro g) and dibutyrylguanosine 3':5'-cyclic monophosphate (db cGMP) (0.1-100 micro g) induced an early (15-30 min) dose-dependent hypernociceptive effect. Intradermal pretreatment with NG-monomethyl-L-arginine (L-NMMA; 50 micro g) inhibited the hypernociception induced by L-Arg (10 micro g), but not that induced by SIN-1 (10 micro g) or db cGMP (10 micro g). 5. Intradermal injection of ODQ (8 micro g) antagonized the hypernociception induced by L-arginine and SIN-1, but not that induced by db cGMP. 6. Considering (a) the different time course of intradermal and subcutaneous PGE(2)-induced hypernociception, (b) the opposite nociceptive effect of intradermal and subcutaneous administration of SIN-1 (db cGMP) as well as the arginine/NO/cGMP pathway, the existence of different subsets of nociceptive primary sensory neurons in which the arginine/NO/cGMP pathway plays opposing roles is suggested. This hypothesis would explain the apparent contradictory observations described in the literature.

Indexed as

AnimalsArginineBucladesineCyclic GMPDermisDinoprostoneDose-Response Relationship, DrugHyperalgesiaInjections, SubcutaneousMaleMolsidomineNitric OxideNociceptorsomega-N-MethylarginineOxadiazolesPain Measurement1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-oneArginineBucladesineCyclic GMPDinoprostonelinsidomineMolsidomineNitric Oxideomega-N-MethylarginineOxadiazolesQuinoxalines

Identifiers

PMID12711636
PMCPMC1573782
OpenAlexW1966176207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.